| ABT |
Report |
Q2 2026 Adjusted EPS |
IN-LINE |
pred ~$1.28 vs. cons $1.28 |
MEDIUM |
| ABT |
Report |
Q2 2026 Total Comparable Sales Growth (incl. full Exact Sciences comp) |
IN-LINE |
pred ~9.8% vs. cons 9.85% |
MEDIUM |
| ABT |
Report |
Diabetes Care / FreeStyle Libre (CGM) comparable sales growth |
MISS |
pred ~8.5% vs. cons ~10.5% (mgmt had explicitly guided a return to double-digit growth) |
MEDIUM |
| ABT |
Guide |
FY2026 comparable sales growth range |
UNCHANGED |
guide ~6.5%-7.5% (reaffirmed, mid ~7.0%) vs. cons ~7.0% (FY2026) |
HIGH |
| ABT |
Guide |
FY2026 adjusted diluted EPS range |
UNCHANGED |
guide ~$5.38-$5.58 (reaffirmed, mid $5.48) vs. cons ~$5.48 (FY2026) |
MEDIUM |
| ABT |
Guide |
Q3 2026 adjusted EPS bridge/guide |
LOWER |
guide ~$1.42-$1.48 vs. cons ~$1.47 (Q3 2026) |
LOW |
| ABT |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.2% |
— |
MEDIUM |
| ABT |
Return |
5-day cumulative residual |
-4.0% (FOLLOW-THROUGH) |
Headline EPS/total comparable sales likely print in-line (mechanically supported by full Exact Sciences consolidation and reaffirmed FY guide), but the market's single most-scrutinized promise — CGM 'return to double-digit growth' in Q2 — is at high risk of missing given weakening U.S. Libre Rx trends and rising CGM competitive/pricing noise already cited in the July 14 sell-off. A miss there, layered on ongoing NEC/infant-formula litigation overhang and structural heart competitive concerns, gives sell-side analysts a concrete reason to trim out-quarter Diabetes Care and Nutrition estimates even if FY26 sales/EPS ranges are nominally reaffirmed — an implicit cut via mix/quality of growth rather than headline guidance. With the stock already down ~28% YTD and multiple consecutive down-legs tied to idiosyncratic (non-print) news, incremental negative revisions on CGM/litigation are more likely to compound over the following days (analysts publish updated models, price-target trims) than to reverse, supporting follow-through rather than a snap-back fade; only a clean double-digit CGM beat would flip this to a relief rally. |
MEDIUM |